Tryptophan

serpin family C member 1 ; Homo sapiens







25 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32194638 A Novel Heterozygous Variant in F2 Gene in a Chinese Patient With Coronary Thrombosis and Acute Myocardial Infarction Leads to Antithrombin Resistance. 2020 1
2 20211924 Replacement of Phe274 with conserved residue Tyr274 for reactive center loop expulsion in antithrombin. 2011 Jun 1
3 18375953 Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombin. 2008 May 23 1
4 16128566 Importance of tryptophan 49 of antithrombin in heparin binding and conformational activation. 2005 Sep 6 2
5 11380262 The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation. 2001 Jun 5 1
6 9722560 Deconvolution of the fluorescence emission spectrum of human antithrombin and identification of the tryptophan residues that are responsive to heparin binding. 1998 Sep 4 11
7 8679610 Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding. 1996 Jul 2 2
8 1412223 Non-specific influence of chemical modification upon the properties of antithrombin III:modification of carboxyl groups. 1992 Aug 15 1
9 2019613 Interaction of poly(sodium vinyl sulfonate) and its surface graft with antithrombin III. 1991 Jan 1
10 2057915 Influence of tryptophan modification upon digestion of antithrombin III by elastase. 1991 Apr 8 2
11 2315891 Influence of chemical modification of tryptophan residues on the properties of human antithrombin III. 1990 Feb 1 5
12 3305015 Probing the heparin-binding domain of human antithrombin III with V8 protease. 1987 Sep 1 1
13 3584126 Antithrombin conformation and the catalytic role of heparin. I. Does cleavage by thrombin induce structural changes in the heparin-binding region of antithrombin? 1987 Jun 5 4
14 3080419 Antithrombin III Basel. Identification of a Pro-Leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity. 1986 Jan 25 1
15 3743657 Anticoagulantly active heparin-like molecules from cultured fibroblasts. 1986 Sep 1
16 6420409 Pyridoxylation of essential lysines in the heparin-binding site of antithrombin III. 1984 Jan 25 1
17 6486808 The role of tryptophan residues in heparin-antithrombin interactions. 1984 Sep 4
18 6693405 The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence. 1984 Jan 25 2
19 6643466 Refolding properties of antithrombin III. Mechanism of binding to heparin. 1983 Nov 25 1
20 7356660 The heparin binding site of antithrombin III. Evidence for a critical tryptophan residue. 1980 Feb 10 3
21 7406509 Tryptophan residue at the heparin binding site in antithrombin III. 1980 Aug 1
22 656463 The increase in human antithrombin III tryptophan fluorescence produced by heparin. 1978 May 24 1
23 710412 The binding of low-affinity and high-affinity heparin to antithrombin. Fluorescence studies. 1978 Sep 15 1
24 24016 Quenching of tryptophan fluorescence in human antithrombin III by iodide ion. 1977 Nov 3
25 65182 Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence. 1977 Jan 25 1